SL-115154 / Shattuck - LARVOL DELTA

Shattuck Labs Reports Third Quarter 2021 Financial Results and Recent Business Highlights (GlobeNewswire) - "Corporate Updates: Shattuck and Takeda Mutually Agree to Termination of Collaboration Agreement: In November 2021, Shattuck and Takeda mutually agreed to termination of the Collaboration Agreement for SL-279252 and SL-115154, originally executed in 2017. Shattuck is no longer required to satisfy any remaining performance obligations, the Company will not make any payments to or receive any future milestone or royalty payments from Takeda, and all options to license and rights of first negotiation held by Takeda under the Collaboration Agreement were terminated."

Licensing / partnership • Oncology